Community-Based Fracture Prevention in High-Risk Populations

Abstract

Fractures represent a significant source of morbidity and mortality, particularly among high-risk populations such as the elderly and individuals with osteoporosis. Community-based strategies have emerged as pivotal in reducing fracture incidence by targeting modifiable risk factors, improving bone health, and promoting early intervention. This review synthesizes current evidence on the epidemiology, pathophysiology, risk stratification, clinical features, diagnostic approaches, management strategies, and guideline recommendations for fracture prevention in high-risk groups, providing practical insights for healthcare professionals.

Introduction

Fracture prevention is a critical public health objective given the aging global population and the substantial burden of osteoporotic and fragility fractures. High-risk populations, including older adults, postmenopausal women, and individuals with chronic comorbidities, are especially vulnerable. Community-based interventions offer a multidimensional approach to fracture prevention, integrating public health, clinical, and behavioral strategies to reduce risk and improve quality of life. This article reviews the latest evidence and practice guidelines to inform optimal fracture prevention in these populations.

Epidemiology / Disease Burden

The global incidence of osteoporotic fractures, particularly hip, vertebral, and wrist fractures, continues to rise, with more than 9 million cases annually. Hip fractures alone account for over 1.6 million cases worldwide each year, with projections suggesting a doubling by 2050. The direct and indirect costs of fractures are substantial, encompassing hospitalization, rehabilitation, long-term care, and loss of independence. Mortality rates following hip fractures remain high, approaching 20% within the first year post-injury. Notably, developing countries are experiencing the fastest growth in fracture incidence, underscoring the need for scalable, community-based prevention strategies.

Pathophysiology

Fracture pathogenesis in high-risk individuals is multifactorial, involving both intrinsic and extrinsic factors. Osteoporosis, characterized by decreased bone mineral density and microarchitectural deterioration, is a central driver. Age-related hormonal changes, particularly estrogen deficiency in postmenopausal women, accelerate bone resorption. Secondary contributors include chronic inflammation, nutritional deficiencies, impaired calcium and vitamin D metabolism, and comorbidities such as diabetes and chronic kidney disease. Falls, often secondary to sarcopenia, balance impairment, or polypharmacy, act as the precipitating event for many fractures in the elderly.

Risk Factors

Major fracture risk factors include advanced age, female sex, prior fragility fractures, family history of osteoporosis, low body mass index, smoking, excessive alcohol consumption, and sedentary lifestyle. Comorbidities such as rheumatoid arthritis, chronic steroid use, and endocrine disorders further heighten risk. Environmental hazards, such as poor lighting, slippery floors, and lack of assistive devices, contribute to fall-related fractures. Risk assessment tools like FRAX® help quantify 10-year fracture risk, guiding targeted intervention in community settings.

Clinical Features

Fractures in high-risk populations often present with acute pain, functional impairment, swelling, and deformity at the affected site. Vertebral fractures may manifest subtly with back pain, height loss, or kyphosis. In the elderly, even minor trauma may result in significant fractures, and symptoms can be atypical or masked by cognitive impairment. Recognition of prodromal symptoms and early signs is crucial for timely diagnosis and intervention.

Diagnosis

Diagnosis begins with a thorough clinical assessment, including history of trauma or falls, physical examination, and evaluation of risk factors. Imaging modalities such as plain radiography and, where indicated, CT or MRI, confirm fracture presence and characterize severity. Bone mineral density assessment via dual-energy X-ray absorptiometry (DXA) remains the gold standard for osteoporosis diagnosis and fracture risk stratification. Laboratory testing may identify secondary causes of bone loss, such as hyperparathyroidism, vitamin D deficiency, or thyroid dysfunction.

Treatment & Management

Management of fractures in high-risk populations encompasses acute fracture care and long-term secondary prevention. Acute management focuses on stabilization, pain control, and early mobilization to prevent complications such as deep vein thrombosis or pressure ulcers. Pharmacologic interventions, including bisphosphonates, denosumab, and selective estrogen receptor modulators, reduce future fracture risk by enhancing bone strength. Non-pharmacologic strategies nutritional optimization, vitamin D and calcium supplementation, resistance and balance exercises, and environmental modifications complement drug therapy. Multidisciplinary fracture liaison services (FLS) have demonstrated efficacy in reducing secondary fractures and improving long-term outcomes.

Recent Advances / Emerging Therapies

Recent advances in fracture prevention include anabolic agents such as romosozumab and teriparatide, which stimulate bone formation and offer alternatives for patients intolerant of antiresorptives. Digital health platforms and telemedicine have facilitated remote monitoring and patient education, improving adherence and outreach in community settings. Personalized risk prediction models leveraging genetic, clinical, and lifestyle data are under development to refine prevention strategies. Community-based exercise programs, such as Tai Chi and multifactorial fall prevention initiatives, have shown promise in reducing falls and fractures among older adults.

Guideline Recommendations

International and national guidelines emphasize a comprehensive, risk-based approach to fracture prevention. The National Osteoporosis Foundation and International Osteoporosis Foundation recommend routine risk assessment for adults over 50, DXA screening for women over 65 and men over 70, and earlier screening for those with risk factors. Pharmacologic therapy is advised for patients with prior fragility fractures or high FRAX® risk. Community-based interventions falls prevention, home hazard assessment, and patient education are integral to guideline-based care. Multidisciplinary team involvement is strongly encouraged to optimize outcomes.

Conclusion

Community-based fracture prevention in high-risk populations is a cornerstone of modern preventive medicine, integrating clinical, behavioral, and public health strategies. Evidence supports the efficacy of targeted risk assessment, pharmacologic and non-pharmacologic interventions, and comprehensive guideline-based approaches. Ongoing research and emerging therapies hold promise for further reducing fracture incidence and improving quality of life among vulnerable populations. Continued collaboration between healthcare providers, public health authorities, and communities will be essential in advancing fracture prevention and addressing the growing global burden.